Abstract
We have investigated the contractile property of cyclosporin A and FK506 in guinea-pig isolated bronchus.
Cyclosporin A (10 μM) failed to significantly attenuate the excitatory non-adrenergic non-cholinergic (eNANC) and cholinergic contractile response (per cent methacholine Emax) induced by electrical field stimulation (EFS). In contrast, eNANC responses were significantly attenuated by both the neurokinin (NK)-1 and (NK)-2 receptor antagonists, N-acetyl-L-tryptophan 3,5-bis (trifluoromethyl)-benzyl and SR48968, respectively.
Cyclosporin A and FK506 caused a concentration-dependent contraction in guinea-pig isolated bronchus, which was significantly attenuated by NK-1 and NK-2 receptor antagonists. The capsaicin receptor antagonist, capsazepine (10 μM) significantly reduced the contractile response to cyclosporin A and capsaicin, but not to FK506.
The N-type calcium channel blocker, ω-Conotoxin (ωCTX: 10 nM), significantly reduced the contractile response to FK506 and the eNANC response following EFS. In contrast, ω-CTX failed to significantly reduce the contractile potency to capsaicin or cyclosporin A.
In bronchial preparations desensitized by repeated application of capsaicin (1 μM), the contractile responses to both cyclosporin A (100 μM) and FK506 (100 μM), were significantly reduced. In contrast, the contractile responses to substance P and neurokinin A (10 μM) were not altered. Furthermore, repeated application of cyclosporin A (100 μM) significantly inhibited the contractile response to capsaicin (1 μM).
The findings from this study would indicate that cyclosporin A and FK506 mediate contraction of guinea-pig isolated bronchus secondary to the release of neuropeptides from airway sensory nerves. However, the release of sensory neuropeptides appears to be mediated via different mechanisms for cyclosporin A and FK506, the former by stimulation of the vanilloid receptor and the latter via opening of N-type calcium channels.
Keywords: Cyclosporin A, FK506, sensory neuropeptides, bronchial smooth muscle, neurotransmitter release, neurokinin-1 and neurokinin-2 receptor antagonists, sensory nerves, capsaicin, capsazepine
Full Text
The Full Text of this article is available as a PDF (313.5 KB).